Trial intelligence / Profile preview

Melatonin 5mg in the Prevention of Delirium in Older Adults Hospitalized in the Emergency Department

NCT04187807Unknown

Sponsor
Universidad Autónoma de San Luis Potosí
Start
Oct 2019
Primary completion
Mar 2020
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial in delirium comparing Melatonin 5mg with Placebo (2 arms). Primary endpoint: Incidence of Delirium at 14 days. Status: unknown.

02

Drugs

melatonin
03

Conditions

delirium

Beyond the preview

Go deeper on NCT04187807.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04187807.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call